GeneDx’s enhancements to its Whole Genome Sequencing (WGS) are poised to significantly impact the landscape of genetic diagnostics. The reduction in turnaround time to just 5 days for Rapid Whole Genome Sequencing (rWGS) is a crucial step in expediting treatment decisions, which can be life-saving in many cases. The introduction of buccal samples for WGS patients marks an important shift towards more accessible and patient-friendly testing options, particularly for younger patients. Furthermore, the expanded coverage of repeat expansions within their WGS offering is expected to enhance diagnostic accuracy, reducing the need for additional follow-up tests. These advancements reinforce GeneDx’s position at the forefront of genomic medicine, leveraging their extensive dataset to deliver precise and timely health insights that promise to improve patient outcomes significantly.